TrialClinical ophthalmology (Auckland, N.Z.)2023

Impact of Modifying Abicipar Manufacturing Process in Patients with Neovascular Age-Related Macular Degeneration: MAPLE Study Results.

David Callanan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.